Ventas, Inc.
NYSE:VTRREIT - Healthcare Facilities
-$0.28 today
- Market cap
- $46.64B
- Beta
- 0.73
- P/E (TTM)
- 149.7
- EPS (TTM)
- $0.55
- Dividend yield
- 2.39%
Volume 3.72M
Average 4.09M
VTR Operating Cash Flow
Cash generated by the company's core business operations during the period.
Ventas, Inc.NYSE: VTR
Operating Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Operating cash flow grows, but more slowly than its trailing trend
Q2 FY2026 operating cash flow of $556.55M rose 17.1% year over year, behind the +19.8% change in trailing-twelve-month operating cash flow. Sequentially, it rose 41.0% from the prior quarter. Over 3 fiscal years it compounded at +13.5% a year.
Context
- Operating cash flow amounted to 28.8% of revenue in FY2025, up 1.6 pp from a year earlier.
- Operating cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +17.1% toward the trailing-twelve-month pace of +19.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 1.68B USD
- Year-over-year change
- +25.6%
- 4-year CAGR
- +12.6%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.68B | +25.6% |
| FY2024 | 2024-12-31 | 1.34B | +12.0% |
| FY2023 | 2023-12-31 | 1.19B | +4.0% |
| FY2022 | 2022-12-31 | 1.15B | +10.0% |
| FY2021 | 2021-12-31 | 1.04B | — |
Operating Cash Flow vs competitors
How VTR compares with its peers on the latest reported figures
- VTR's LTM Jun 2026 operating cash flow of $1.84B is the 2nd largest of the 11 companies compared; the peer median is $393.16M.
- Its year-over-year change of +19.8% is the 3rd highest of 10, against a peer median of +3.4%.
- Operating cash flow amounts to 28.5% of revenue for VTR, versus a peer median of 33.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.52B | -9.4% | +29.4% | 18.4% | |
| LTM Jun 2026 | $1.84B | +19.8% | +13.5% | 28.5% | |
| LTM Sep 2026 | $916.07M | -26.2% | +11.6% | 40.8% | |
| LTM Jun 2026 | $890.56M | +6.5% | +12.0% | 68.9% | |
| LTM Sep 2026 | $500.96M | +43.8% | +39.7% | 81.4% | |
| LTM Sep 2026 | $414.75M | +38.8% | +25.8% | 15.5% | |
| LTM Jun 2026 | $371.57M | +9.7% | +3.4% | 43.2% | |
| LTM Sep 2026 | $236.24M | +3.4% | +9.0% | 51.7% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $164.38M | -12.6% | -32.2% | 16.1% |
| LTM Sep 2026 | $103.08M | -21.5% | +8.8% | 26.2% | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $6.95M | — | — | 2.0% |
| Peer median (excluding VTR) | $393.16M | +3.4% | +11.6% | 33.5% | |
Competitors are the stored peer set for VTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 49.01M | (47.45M) | (40.97M) | 81.15M | 251.38M |
| Depreciation & Amortization | 978M | 1.09B | 1.17B | 1.17B | 1.38B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (43.77M) | (40.79M) | (53.6M) | 43.81M | 49.43M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 16.72M | 7.2M | (6.41M) | 133.97M | 81.04M |
| Other Working Capital | (60.49M) | (47.98M) | (47.19M) | (90.16M) | (31.61M) |
| Other Non-Cash Items | 60.72M | 146.71M | 123.25M | 45.89M | 475K |
| Operating Cash Flow | 1.04B | 1.15B | 1.19B | 1.34B | 1.68B |
| Capital Expenditures | (185.28M) | (222.13M) | (259.42M) | (281.61M) | (363.86M) |
| Acquisitions (Net) | (22.49M) | 5.2M | 31.75M | (7.36M) | (1.98M) |
| Purchases of Investments | (1.75B) | (792.92M) | (523.33M) | (2.44B) | (2.63B) |
| Sales of Investments | 1.19B | 113.82M | 494.22M | 335.96M | 261.98M |
| Other Investing Activities | 1.29M | 13.7M | 17.58M | 3.54M | 5.01M |
| Investing Cash Flow | (764.48M) | (882.33M) | (239.2M) | (2.39B) | (2.73B) |
| Debt Repayment | (447.96M) | 468.8M | 97.75M | 249.13M | (670.52M) |
| Common Stock Issued | 625.61M | 8.69M | 109.06M | 1.99B | 2.45B |
| Common Stock Repurchased | (96K) | (1.49M) | 0 | 0 | 0 |
| Dividends Paid | (686.89M) | (720.32M) | (723.56M) | (740.33M) | (860.06M) |
| Other Financing Activities | (26.64M) | (44.82M) | (47.13M) | (44.73M) | (45.94M) |
| Financing Cash Flow | (535.97M) | (289.13M) | (563.88M) | 1.45B | 875.73M |
| Effect of Forex Changes | 1.45M | (2.87M) | 1.26M | (3.99M) | 2.84M |
| Net Change in Cash | (255.04M) | (25.85M) | 392.72M | 393.77M | (171.1M) |
| Free Cash Flow | 858.69M | 926.34M | 935.13M | 1.06B | 1.32B |
Ventas, Inc.
NYSE:VTR
Intrinsic Alpha fair value
Locked
Current Price
$88.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.